The FDA late Monday approved sales of Trelegy Ellipta, developed jointly by GlaxoSmithKline PLC and Innoviva Inc. It contains three widely used types of medicine to prevent - rather than treat -flare-ups of the life-threatening breathing disorders.
Researchers discover a large number of mutations clustered in a single gene that disrupt the development of the brain’s connections and likely contribute to the development of autism-spectrum disorders.
In a new paper, researchers describe a new paradigm for treating transcription factor-driven cancers. The study focuses on Ewing sarcoma and how the EWS/FLI transcription factor drives the malignancy – and suggests ways to disrupt the process.
The latest versions of most smartphones contain at least two and sometimes three built-in cameras. Researchers at the University of Illinois would like to sell mobile device manufactures on the idea of adding yet another image sensor as a built-in capability for health diagnostic, environmental monitoring, and general-purpose color sensing applications.
The latest development in a technique known as ‘nanokicking’ has allowed scientists from the Universities of Glasgow, Strathclyde, the West of Scotland and Galway to grow three-dimensional samples of mineralised bone in the laboratory for the first time.